AQR Capital Management
AVEO

AQR Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

AQR Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q4 		– Sell
-13,249
Closed -$79K – 2317
2020
Q3 		$79K Buy
+13,249
New +$65.5K ﹤0.01% 2152
2019
Q1 		– Sell
-1,126
Closed -$18K – 2268
2018
Q4 		$18K Sell
1,126
-6,585
-85% -$145K ﹤0.01% 2174
2018
Q3 		$255K Sell
7,711
-8,118
-51% -$209K ﹤0.01% 2143
2018
Q2 		$358K Buy
+15,829
New +$375K ﹤0.01% 2080
2014
Q1 		– Sell
-9,520
Closed -$175K – 2660
2013
Q4 		$175K Sell
9,520
-25,420
-73% -$509K ﹤0.01% 2451
2013
Q3 		$723K Sell
34,940
-56,811
-62% -$1.3M ﹤0.01% 1815
2013
Q2 		$2.29M Buy
+91,751
New +$3.92M 0.01% 1197

Other funds holding AVEO

NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
SAM
Sectoral Asset Management Montreal, Quebec, Canada $121M AUM 73.47% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Squarepoint
Squarepoint New York $85.1B AUM 20.93% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return

AQR Capital Management's AVEO Position: Q4 2020 in Review

AQR Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q4 2020, closing a stake of 13,249 shares — an estimated $79K sold.

AQR Capital Management first reported a position in AVEO in Q2 2013 and held it in 7 quarters. The position peaked at $2.29M in Q2 2013. 65 funds tracked by Wall St. Rank hold AVEO as of Q4 2020.

  • AQR Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
  • AQR Capital Management sold 13,249 AVEO Pharmaceuticals, Inc. shares in Q4 2020, an estimated $79K.
  • AQR Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q2 2013 and held it in 7 quarters.
  • AQR Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $2.29M in Q2 2013.
  • 65 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q4 2020.

Based on AQR Capital Management's 13F filing for Q4 2020, filed 16 Feb 2021.